Max Rosett Insider Trades & Stock Holdings

Chief Financial Officer · Immunome, Inc. · Latest filing Jun 15, 2026

Max Rosett, Chief Financial Officer at Immunome, Inc. has 1 Form 4 trade on file since Jun 15, 2026. Latest filing: disposed of 60K shares of $IMNM on Jun 15, 2026.

Trades on file
1
Open-market bought
$0
Open-market sold
$0
Net open-market
$0
Latest filing
Jun 15, 2026

All insider trades by Max Rosett

DateTicker TypeSharesPriceValue Owned afterΔOwn 1W1M6MRoleFilingStory
$IMNM Sell (Option exercise) 60K $0 — +6.1%+26.8% Chief Financial Officer Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Max Rosett traded

Frequently asked questions

What was Max Rosett's latest insider trade?

disposed of 60K shares of $IMNM on Jun 15, 2026.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text